Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 10M-17-3
PHII-143 A Phase 2 Study of Ibrutinib (PCI-32765) in Refractory Distant Metastatic Cutaneous Melanoma: Correlation of Biomarkers with Response and Resistance
Type:
Treatment
Phase:
Phase II
Status:
Not Open (Closed)
Treatments:
Immunotherapy
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Gino In, M.D.
Other Trial Staff:
Ramona Lujan, Coordinator, Lusine Raddatz, D.M., Victoria Amran, D.M., Gina Tse, Coordinator, Shamim Jhimlee, Coordinator, Laurie De Oliveira, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.